Table 1.

Estimated total costs and reimbursement used in cost-effectiveness model.

Charge list	Costs (CNY)	Costs (USD)
PSA tests, range*	128	19
phi test, range	500–900	72–130
Biopsy procedure
Ultrasonography	385	56
Prostate Biopsy	779	113
Medicine**	111	16
Pathological tests	900	130
Total	2,175	315
Reimbursement, mean (SD)	1,781 (305)	258 (44)

PSA, prostate-specific antigen; phi, prostate health index; CNY, Chinese yuan; USD, United States dollar.

^*PSA tests included both tPSA and fPSA test.

^**Medicine included both anesthetic and antibiotic drugs.